You're talking about a trial that happened mid to end of 2020 before the delta variant (new strain) took hold, if you look up pfizer ect they all had similar efficacy against the original variant.
Currently there is no formal large scale peer reviewed results for moderna against the delta variant so you will find many small scale studies with very wide results from as low as 40% to as high as 95% efficacy against delta.
Below is the trail study from Moderna's "94%" results and associated information
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html
https://www.cdc.gov/mmwr/volumes/69/wr/mm695152e1.htm?s_cid=mm695152e1_w
https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/reactogenicity.html
https://www.fda.gov/media/144434/download
You're talking about a trial that happened mid to end of 2020...
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.0¢ |
Change
-0.010(1.96%) |
Mkt cap ! $115.8M | |||
| Open | High | Low | Value | Volume |
| 53.0¢ | 55.0¢ | 50.0¢ | $168.7K | 317.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6252 | 48.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 13561 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| RCE (ASX) Chart |